Verve Therapeutics's market cap is currently $718.37M. The company's EPS TTM is $-2.463; its P/E ratio is ―; Verve Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 11.76M	$ 1.94M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 6.30M	$ -4.77M	$ -3.38M	$ -1.33M	$ -106.00K
Operating Income	$ -223.12M	$ -165.69M	$ -87.07M	$ -40.63M	$ -13.64M
EBITDA	$ -217.67M	$ -162.88M	$ -85.53M	$ -39.30M	$ -13.54M
Net Income	$ -200.07M	$ -157.39M	$ -118.64M	$ -45.54M	$ -19.02M
Balance Sheet
Cash & Short-Term Investments	$ 623.95M	$ 554.81M	$ 360.44M	$ 72.11M	$ 18.78M
Total Assets	$ 752.69M	$ 679.22M	$ 384.12M	$ 78.41M	$ 21.65M
Total Debt	$ 74.91M	$ 81.92M	$ 1.96M	$ 125.16M	$ 35.05M
Net Debt	$ -131.27M	$ -33.49M	$ -62.38M	$ 116.17M	$ 32.06M
Total Liabilities	$ 153.19M	$ 128.29M	$ 26.77M	$ 142.32M	$ 41.20M
Stockholders' Equity	$ 599.50M	$ 550.93M	$ 357.35M	$ -63.91M	$ -19.55M
Cash Flow
Free Cash Flow	$ -158.83M	$ -135.56M	$ -82.24M	$ -38.69M	$ -9.30M
Operating Cash Flow	$ -149.55M	$ -122.33M	$ -77.88M	$ -35.27M	$ -7.44M
Investing Cash Flow	$ 27.69M	$ -155.96M	$ -239.10M	$ -51.13M	$ -12.76M
Financing Cash Flow	$ 212.58M	$ 328.96M	$ 377.09M	$ 92.63M	$ 17.95M

Currency in USD

Verve Therapeutics Earnings and Revenue History

Income Statement >

Verve Therapeutics Debt to Assets

Balance Sheet >

Verve Therapeutics Cash Flow

Cash Flow >

Verve Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing